30 Oct 2017 - Business Times Breaking News
THIRD-QUARTER earnings for Tianjin Zhong Xin Pharmaceutical Group sank 8 per cent to 83.3 million yuan (S$17.1 million) from the previous year.For the three months ended Sept 30, revenue fell 14 per cent to 1.31 billion yuan from a year ago, the group said in a Singapore Exchange filing on Monday evening.Tianjin ...
sgx:t14